Zacks Investment Management Charles River Laboratories International, Inc. Transaction History

Zacks Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $2.18 Million - $2.51 Million	-17,462 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $5,306 - $6,387	-43 Reduced 0.25%	17,462 $2.48 Million
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $176,412 - $246,946	-1,683 Reduced 8.77%	17,505 $2.54 Million
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $63,159 - $82,475	601 Added 3.23%	19,188 $2.17 Million
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $109,307 - $131,176	975 Added 5.54%	18,587 $2.5 Million
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $106,157 - $121,588	1,037 Added 6.26%	17,612 $1.98 Million
Q1 2018 May 14, 2018	BUY	$98.19 - $115.2 $142,179 - $166,809	1,448 Added 9.57%	16,575 $1.77 Million
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $29,928 - $35,190	298 Added 2.01%	15,127 $1.66 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $1.43 Million - $1.62 Million	14,829	14,829 $1.6 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.